Validation and extension of the EBMT Risk Score for patients with chronic myeloid leukaemia (CML) receiving allogeneic haematopoietic stem cell transplants

British Journal of Haematology

Volumn 125, Issue 5, 2004, Pages 613-620

  Passweg, Jakob R ^a   Walker, Irwin ^b   Sobocinski, Kathleen A ^c   Klein, John P ^c   Horowitz, Mary M ^c   Giralt, Sergio A ^d  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b MCMASTER UNIVERSITY   (Canada)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Chronic myeloid leukaemia; Haematopoietic stem cell transplantation; Risk assessment; Risk score; Validation

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER PATIENT; CANCER REGISTRY; CANCER SURVIVAL; CHILD; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; FEMALE; GRAFT REJECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PUBLICATION; RISK ASSESSMENT; SCORING SYSTEM; SURVIVAL RATE; VALIDATION PROCESS;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; INFANT, NEWBORN; LEUKEMIA, MYELOID, CHRONIC; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; SURVIVAL ANALYSIS; TRANSPLANTATION, HOMOLOGOUS;

EID: 2942511357     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2004.04955.x     Document Type: Article

References (12)

1. Broers, A.E.C., van der Holt, R., van Esser, J.W.J., Gratama, J-W., Henzen-Logmans, S., Kuenen-Boumeester, V., Löwenberg, B. & Cornelissen, J.J. (2000) Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplantation. Blood, 95, 2240-2245.
2. Gale, R.P., Hehlmann, R., Zhang, M-J., Hasford, J., Goldman, J.M., Heimpel, H., Hochhaus, A., Klein, J.P., Kolb, H-J., McGlave P.B., Passweg, J.R., Rowlings, P.A., Sobocinski, K.A. & Horowitz, M.M. (1998) Survival with bone marrow transplantation versus hydroxyurea or interferon for chronic myelogenous leukemia. Blood, 91, 1810-1819.
3. Goldman, J.M., Apperley, J.F., Jones, L., Marcus, R., Goolden, A.W., Batchelor, R., Hale, G., Waldmann, H., Reid, C.D., Hows, J., Gordon-Smith, E., Catovsky, D. & Galton, D.A.G. (1986) Bone marrow transplantation for chronic myeloid leukemia. The New England Journal of Medicine, 314, 202-207.
4. Gratwohl, A., Hermans, J., Goldman, J.M., Arcese, W., Carreras, E., Devergie, A., Frassoni, F., Gahrton, G., Kolb, H-J., Niederwieser, D., Ruutu, T., Vernant, J.P., de Witte, T. & Apperley, J. (1998) Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. The Lancet, 352, 1087-1092.
5. Hasford, J., Pfirrmann, M., Hehlmann, R., Allan, N.C., Baccarani, M., Kluin-Nelemans, J.C., Alimena, G., Steegmann, J.L. & Ansari, H. (1998) A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Journal of the National Cancer Institute, 90, 850-858.
6. Klein, P.J. & Moeschberger, M.L. (1997) Survival Analysis: Techniques for Censored and Truncated Data. Springer-Verlag, New York.
7. O'Brien, S.G., Guilhot, F., Larson, R.A., Gathmann, I., Baccarani, M., Cervantes, F., Cornelissen, J.J., Fischer, T., Hochhaus, A., Hughes, T., Lechner, K., Nielsen, J.L., Rousselot, P., Reiffers, J., Saglio, G., Shepherd, J., Simonsson, B., Gratwohl, A., Goldman, J.M., Kantarjian, H., Taylor, K., Verhoef, G., Bolton, A.E., Capdeville, R. & Druker, B.J. for the IRIS Investigators. (2003) Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. The New England Journal of Medicine, 348, 994-1004.
8. Schemper, M. & Henderson, R. (2000) Predictive accuracy and explained variation in Cox regression. Biometric, 56, 249-255.
9. Sokal, J.E., Cox, E.B., Baccarani, M., Tura, S., Gomez, G.A., Robertson, J.E., Tso, C.Y., Braun, T.J., Clarkson, B.D., Cervantes, F., Rozmann, C. & The Italian Cooperative CML Study Group. (1984) Prognostic discrimination in 'good-risk' chronic granulocytic leukemia. Blood, 63, 789-799.
10. Sokal, J.E., Baccarani, M., Tura, S, Fiacchini, M., Cervantes, F., Rozman, C., Gomez, G.A., Gallon, D.A.G., Canellos, G.P., Braun, T.J., Clarkson, B.D., Carbonell, F., Heimpel, H., Extra, J.M., Fiere, D., Nissen, N.I., Robertson, I.E. & Cox, E.B. (1985) Prognostic discrimination among younger patients with chronic granulocytic leukemia: relevance to bone marrow transplantation. Blood, 66, 1352-1357.
11. Speck, B., Bortin, M.M., Champlin, R., Goldman, J.M, Herzig, R.H., McGlave, P.B., Messner, H.A., Weiner, R.S. & Rimm, A.A. (1984) Allogeneic marrow transplantation for chronic myelogenous leukaemia. The Lancet, 1, 665-668.
12. Thomas E.D., Clift R.A., Fefer A., Appelbaum, F.R., Beatty, P., Bensinger, W.I., Buckner, C.D., Cheever, M.A., Deeg, H.J., Doney, K., Flournoy, N., Greenberg, P., Hansen, J.A., Martin, P., McGuffin, R., Ramberg, R., Sanders, J.E., Singer, J., Stewart, P., Storb, R., Sullivan, K., Weiden, P.L. & Witherspoon, R. (1988) Marrow transplantation for the treatment of chronic myelogenous leukemia. Annals of Internal Medicine, 104, 155-163.